ATE86668T1 - Antidiabetikaverbindungen. - Google Patents

Antidiabetikaverbindungen.

Info

Publication number
ATE86668T1
ATE86668T1 AT85304163T AT85304163T ATE86668T1 AT E86668 T1 ATE86668 T1 AT E86668T1 AT 85304163 T AT85304163 T AT 85304163T AT 85304163 T AT85304163 T AT 85304163T AT E86668 T1 ATE86668 T1 AT E86668T1
Authority
AT
Austria
Prior art keywords
diabetic compounds
compounds
present
diabetic
insulin
Prior art date
Application number
AT85304163T
Other languages
English (en)
Inventor
Bruce Hill Frank
Allen Howard Pekar
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE86668T1 publication Critical patent/ATE86668T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT85304163T 1984-06-14 1985-06-12 Antidiabetikaverbindungen. ATE86668T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/620,781 US4581165A (en) 1984-06-14 1984-06-14 Anti-diabetic compounds
EP85304163A EP0171887B1 (de) 1984-06-14 1985-06-12 Antidiabetikaverbindungen

Publications (1)

Publication Number Publication Date
ATE86668T1 true ATE86668T1 (de) 1993-03-15

Family

ID=24487362

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85304163T ATE86668T1 (de) 1984-06-14 1985-06-12 Antidiabetikaverbindungen.

Country Status (7)

Country Link
US (1) US4581165A (de)
EP (1) EP0171887B1 (de)
JP (1) JPS6110599A (de)
AT (1) ATE86668T1 (de)
CA (1) CA1244365A (de)
DE (1) DE3587164T2 (de)
DK (1) DK262585A (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888414A (en) * 1987-04-09 1989-12-19 Board Of Regents, University Of Texas System Insulin-binding peptides and uses thereof
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
US4992417A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogues
US5208217A (en) * 1989-04-20 1993-05-04 Mount Sinai School Of Medicine Of The City University Of New York Hepatospecific insulin analogues
JPH05252941A (ja) * 1991-08-12 1993-10-05 Sakai Enetsukusu Kk 動物細胞培養用担体
CZ342492A3 (en) * 1991-11-26 1993-06-16 Lilly Co Eli Derivatives of tri-arginine insulin, process of their preparation and a pharmaceutical composition in which said derivatives are comprised
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
KR100730872B1 (ko) 1999-12-30 2007-06-20 코닝 인코포레이티드 팬던트 히드록실 관능기를 갖는 모노머를 포함하는 1차코팅제 조성물로 제조된 광섬유
EP1250386A1 (de) 1999-12-30 2002-10-23 Corning Incorporated Klebemittelenthaltende zusammensetzung und verfahren zur veränderung von zeitempfindlichen rheologischen eigenschaften einer optischen faserbeschichtung
KR20020067061A (ko) 1999-12-30 2002-08-21 코닝 인코포레이티드 광섬유용 2차 코팅 조성물
US6775451B1 (en) 1999-12-30 2004-08-10 Corning Incorporated Secondary coating composition for optical fibers
EP1254082A1 (de) 1999-12-30 2002-11-06 Corning Incorporated Schnellhärtende primärbeschichtung für optische faser
WO2001072323A2 (en) 2000-03-24 2001-10-04 Genentech, Inc. Use of insulin for the treatment of cartilagenous disorders
US6584263B2 (en) 2000-07-26 2003-06-24 Corning Incorporated Optical fiber coating compositions and coated optical fibers
US6553169B2 (en) 2000-11-29 2003-04-22 Corning Incorporated Optical fiber coating compositions and coated optical fibers
US6602601B2 (en) 2000-12-22 2003-08-05 Corning Incorporated Optical fiber coating compositions
US20030077059A1 (en) * 2001-03-13 2003-04-24 Ching-Kee Chien Optical fiber coating compositions
US6628875B2 (en) 2001-07-20 2003-09-30 Corning Incorporated Optical fibers possessing a primary coating with a higher degree of cure and methods of making
US7050688B2 (en) * 2003-07-18 2006-05-23 Corning Cable Systems Llc Fiber optic articles, assemblies, and cables having optical waveguides
US7715675B2 (en) * 2003-07-18 2010-05-11 Corning Incorporated Optical fiber coating system and coated optical fiber
US9678247B2 (en) 2012-05-08 2017-06-13 Corning Incorporated Primary optical fiber coating composition containing non-radiation curable component
US9488774B2 (en) 2014-04-01 2016-11-08 Corning Incorporated Primary optical fiber coating composition containing non-radiation curable component
US9708491B2 (en) 2014-06-04 2017-07-18 Corning Incorporated Optical fiber coating and composition
US9891379B2 (en) 2014-11-14 2018-02-13 Corning Incorporated Optical fiber coating compositions with acrylic polymers
US20160177092A1 (en) 2014-12-18 2016-06-23 Corning Incorporated Optical fiber coating composition with non-reactive reinforcing agent
US10640654B2 (en) 2015-12-07 2020-05-05 Corning Incorporated Optical fiber coating and composition with UV-absorbing additive

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3209184A1 (de) * 1982-03-13 1983-09-15 Hoechst Ag, 6230 Frankfurt Verfahren zur umwandlung von praeproinsulinanaloga zu insulinen

Also Published As

Publication number Publication date
DE3587164T2 (de) 1993-07-15
EP0171887A2 (de) 1986-02-19
DK262585A (da) 1985-12-15
DE3587164D1 (de) 1993-04-15
EP0171887B1 (de) 1993-03-10
DK262585D0 (da) 1985-06-12
JPS6110599A (ja) 1986-01-18
EP0171887A3 (en) 1989-01-25
CA1244365A (en) 1988-11-08
US4581165A (en) 1986-04-08

Similar Documents

Publication Publication Date Title
ATE86668T1 (de) Antidiabetikaverbindungen.
EG15458A (en) Improvements in or relating to 3-aryloxy-3-phenylpropylamines
DK0486948T3 (da) Forbindelser, der hæmmer retrovirale proteaser
IT8919413A0 (it) Composizione avente attivita' battericida oppure batteriostatica.
ATE87662T1 (de) Antidiabetikaverbindungen.
ATE87661T1 (de) Antidiabetikaverbindungen.
DK0566175T3 (da) 3,4-diaryl-(5H)-furan-2-on-baserede forbindelser med fungicid aktivitet
IT8422150A0 (it) Composti dotati di attivita'antiallergica.
DE3575681D1 (de) Dispergierende salze.
SU1095611A1 (ru) Хлорид 5-хлорметил-2-этил-8-метил-4Н-м-диоксино-(4,5-с)-пиридиния, обладающий антимикробной активностью
DE3577899D1 (de) Cyanuersaeure enthaltende waessrige zusammensetzungen.
IT8420775V0 (it) Corpo musicale, nonche' di illuminazione, automatico.
IT8522424A0 (it) Composto ad attivita'pilostimolante.
IT8420075A0 (it) Composti ad attivita'antibatterica.
SU1319521A1 (ru) 5-(2,2,2-Трифтор-1-окси-1-трифторметилэтил)фурил-2-метилгидразонийбромид, проявляющий антимикробную и противовоспалительную активность
SU1202241A1 (ru) Натриевая соль 5-n-хлорбензилидентиазолидиндиона-2,4, обладающая противогрибковой активностью
SU1302661A1 (ru) 3-(3,5-Диметилпиразолил-1)-6-(2-карбэтокси-1-метилэтилиден-1)гидразинопиридазин, обладающий противовоспалительной и противомикробной активностью
SU1455632A1 (ru) О,о-диэтил-n-(1-пропилтио-2-гидрокси-2-метилпропилиден)-амидотиофосфат, обладающий бактерицидной активностью
SU1221874A1 (ru) 1,1-Этилиденди-(5-нитро-2-фуроиламин), проявляющий противомикробную и противовоспалительную активность
SU1374724A1 (ru) 1-фосфонометил-2-иминоимидазолидин-4-он, обладающий гербицидной активностью
SU1410453A1 (ru) 2-[(пентадециламино)метил]фенол, обладающий бактериостатической, бактерицидной и спороцидной активностью
SU961332A1 (ru) [5-(2,2-Диметил-4,6-диоксо-1,3-диоксан-5-метенил)фурил-2]-(бензотиазолил-2) сульфид, проявляющий антимикробную активность
SU1610823A1 (ru) S-трет-бутилтиуронийбромид, обладающий антиишемической активностью
IT8423967A0 (it) Composti eterociclici dotati di attivita' terapeutica.
IT8323995A0 (it) Composto ad attivita'antiipertensiva.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee